Chestnykh D, Mühle C, Schumacher F, Kalinichenko LS, Löber S, Gmeiner P, Alzheimer C, von Hörsten S, Kleuser B, Uebe S, Ekici AB, Gulbins E, Kornhuber J, Jin HK, Bae JS, Lourdusamy A, Müller CP. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Mol Psychiatry. 2025 30(7):2891-2906. Epub 2025 Jan 17.
Lim TV, Cardinal RN, Ziauddeen H, Regenthal R, Sahakian BJ, Robbins TW, Ersche KD. Atomoxetine reduces decisional impulsivity in human cocaine addiction. Biol Psychiatry. 2025 97(6):627-636. Epub 2024 Oct 29.
Salamian A, Pagano R, Skonieczna E, Kalinichenko LS, Puchalska M, Yiğit Ünlü G, Gajewska-Woźniak O, Kruashvili L, Grochowicz M, Wojtas B, Gielniewski B, Harda Z, Cały A, Mühle C, Lenz B, Kornhuber J, Lourdusamy A, Havekes R, Abel T, Müller CP, Radwanska K. Hippocampal Cofilin and CFL1 gene variants are linked to Alcohol Use Disorder phenotypes. Mol Psychiatry. 2025 Sep 11. [Epub ahead of print]
Türkmen C, Machunze N, Lee AM, Bougelet E, Ludin NM, de Cates AN, Vollstädt-Klein S, Bach P, Kiefer F, Andreas JB, Kamphuis J, Schoevers RA, Emslie GJ, Hetrick SE, Viechtbauer W, van Dalfsen JH. Systematic Review and Meta-Analysis: The Association Between Newer Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2025 64(10):1148-1164. Epub 2025 Jan 17.
Zimmermann S, Teetzmann A, Baeßler J, Schreckenberger L, Zaiser J, Pfisterer M, Stenger M, Bach P. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025 30(6):2612-2619. Epub 2024 Dec 12.